Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

UBS Maintains Neutral on Ambev, Lowers Price Target to $2.2

Author: Benzinga Newsdesk | August 20, 2025 01:39pm
UBS analyst Rodrigo Alcantara maintains Ambev (NYSE:ABEV) with a Neutral and lowers the price target from $2.5 to $2.2.

Posted In: ABEV

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist